Brainstorm Cell Therapeutics

Stacy Lindborg, Ph.D., EVP and Head of Global Clinical Research
New York, NY
(NASDAQ: BCLI)
Brainstorm Cell Therapeutics is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amytrophic Lateral Scelorosis (ALS, also known as Lou Gherig Disease) Progressive MS, and other neurodegenerative diseases.
www.brainstorm-cell.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions